The first panel discussion in the Voices for Health series is on the growing epidemic of Antibiotic Resistance will be held in Hyderabad on 1 March 2016. This event is being jointly organised by Wellcome Trust/DBT India Alliance, Manthan-India, Public Health Foundation of India,Centre for DNA Fingerprinting and Diagnostics, 17th International
Congress on Infectious Diseases (ICID)
Antibiotic resistance in India
Last year’s Noble prize in Medicine and Physiology, applauding the discoveries concerning novel therapies against infections, is in grim contrast with global health epidemic of Antibiotic Resistance that the world is facing today. Antibiotic resistance, which is more broadly classified as Antimicrobial Resistance (AMR), can be loosely defined as resistance of the infectious bugs against the medications used to eliminate them. AMR has fast become an obstacle in the prevention and treatment of variety of infections caused by bugs such as bacteria, parasites, viruses and fungi, which cause HIV, influenza, malaria, tuberculosis and host of other infections and is being called the "single biggest health threat of the 21st century "
Antibiotics are one of the most commonly used medication across the world. However, it is important to note that in most countries 80% of antibiotics are used outside hospitals and healthcare facilities, either with a preion from a healthcare provider or are obtained directly from pharmacies without one. 20-50% of this outside the hospital use is inappropriate and unnecessary. According to the 2015 report by Center for Disease Dynamics, Economics & Policy (CDDEP), on average, an Indian citizen consumed about 7.4 antibiotic pills (per year) in 2000, which increased to about 11.7 antibiotic pills in 2010. The report also revealed that between 2000 and 2010, antibiotic consumption increased by 36%. Of the five countries, Brazil, Russia, India, China and South Africa (BRICS) that accounted for 76% of this increase in antibiotic consumption, India had the highest antibiotic consumption. The unfortunate consequence of this use has brought us at the brink of what could be a deadly epidemic of antibiotic resistance that could have damaging and long-lasting consequences in a country like India. This discussion will briefly explore socio-cultural, economic, environmental, scientific and medical dimensions of the problem and suggest strategies on how key stakeholders can come together to spread awareness and fight antibiotic/microbial resistance.
Following speakers will be talking at this event,
Dr Ramanan Laxminarayan (moderator) is Director at Center for Disease Dynamics, Economics & Policy. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource
Dr Sanjeev Singh is a Medical Superintendent, Head Infection Control, Head Quality and Standards & Head Hospital Information Systems at Amrita Institute of Medical Sciences, Kochi, Kerela. He is the Joint Secretary of Hospital Administrators, regional Directors of Indian Society of Health Administrators and members of national Initiative of Patient Safety.
Dr Dilip Nathwani is an honorary Professor of Infection at the University of Dundee. Director of Medical Education Scotland, National Speciality Adviser for Infectious Diseases to the Scottish Government Health Department and President-elect of the British Society for Antimicrobial Chemotherapy (BSAC)
Dr Radha Rangarajan is CEO of Vitas Pharma in Hyderabad, a women-led discovery company in Hyderabad which is working on identifying and developing therapies for multidrug resistant hospital acquired infections.
Voices for Health: Voices for Health is an effort aimed at engaging people and communities to better understand public health and to educate them about key determinants of emergent heath issues. This initiative is planned as a series of public engagement events that will bring together biomedical researchers with policy makers, social scientists, health workers, media and other stakeholders to talk about important health issues. Each event will focus on a public health topic of contemporary interest. The series will aim to demystify science and myths, disseminate latest health research and share perspectives of experts and people. The first of the series focuses on antibiotic resistance.